Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP227405.RA3iTID1bYONgoQI2Ky-YJzENWkQDEBOc8zOCU_NHumDE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP227405.RA3iTID1bYONgoQI2Ky-YJzENWkQDEBOc8zOCU_NHumDE130_assertion type Assertion NP227405.RA3iTID1bYONgoQI2Ky-YJzENWkQDEBOc8zOCU_NHumDE130_head.
- NP227405.RA3iTID1bYONgoQI2Ky-YJzENWkQDEBOc8zOCU_NHumDE130_assertion description "[Generalized alterations in beta-adrenergic signalling, including betaARK1, could be a major contributory factor in the development of LVH in hypertension, and the concentration of betaARK1 in lymphocytes can reflect the development of LVH in a patient with hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227405.RA3iTID1bYONgoQI2Ky-YJzENWkQDEBOc8zOCU_NHumDE130_provenance.
- NP227405.RA3iTID1bYONgoQI2Ky-YJzENWkQDEBOc8zOCU_NHumDE130_assertion evidence source_evidence_literature NP227405.RA3iTID1bYONgoQI2Ky-YJzENWkQDEBOc8zOCU_NHumDE130_provenance.
- NP227405.RA3iTID1bYONgoQI2Ky-YJzENWkQDEBOc8zOCU_NHumDE130_assertion SIO_000772 15097244 NP227405.RA3iTID1bYONgoQI2Ky-YJzENWkQDEBOc8zOCU_NHumDE130_provenance.
- NP227405.RA3iTID1bYONgoQI2Ky-YJzENWkQDEBOc8zOCU_NHumDE130_assertion wasDerivedFrom befree-20150227 NP227405.RA3iTID1bYONgoQI2Ky-YJzENWkQDEBOc8zOCU_NHumDE130_provenance.
- NP227405.RA3iTID1bYONgoQI2Ky-YJzENWkQDEBOc8zOCU_NHumDE130_assertion wasGeneratedBy ECO_0000203 NP227405.RA3iTID1bYONgoQI2Ky-YJzENWkQDEBOc8zOCU_NHumDE130_provenance.